RXRA and central nervous system cancer: It has recently been shown that FABP7 translocates to the nucleus and interacts with nuclear factors (e.g., ACLY, RXRα) to modulate gene expression associated with cellular physiology and metabolism in both astrocytes and glioma cells [23,24,25].